{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P08684",
      "entity_text" : "CYP3A4",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:2754",
      "entity_text" : "cilostazol",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Concurrent use of cilostazol and potent inhibitors of CYP3A4 or CYP2C19 also decreased in all databases.",
  "reading_complete" : "2020-08-05T21:10:30Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T21:09:25Z",
  "trigger" : "inhibitors",
  "evidence" : [ "cilostazol and potent inhibitors of CYP3A4" ],
  "pmc_id" : "6175151",
  "score" : 0
}